Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
2025;47:e-rbgo22
For the composite endpoint of 1.0%-point HbA1c reduction with weight loss 3.0%, the cost of control was USD 525 lower with oral semaglutide 14 mg than with empagliflozin 25 mg
Presented for research literature review only Pang SF et al
Book a free discovery call virtually (Ontario residents only).
Approval requires extensive clinical trial data covering safety, effectiveness, manufacturing quality, and long-term monitoring
24 Small molecules may offer advantages such as improved tissue permeability, longer half-lives, and lower production costs
US$ 26.01
US$ 23.40
US$ 25.18
